Capital raised by GelMEDIX
1 Form D filing · first filed Oct 2025 · Cambridge, MA
President and CEO
Signatory on GelMEDIX's Form D filings · $747K raised across 1
Max Cotler is on file as President and CEO at GelMEDIX in Cambridge, MA. GelMEDIX has 1 Form D filing on record, $747K raised in total. Max Cotler appears as a signatory on the company's filings.
LinkedIn profileA retinal pigment epithelial (RPE) cell therapy delivered in GelMEDIX's injectable hydrogel scaffold, in preclinical development for late-stage Geographic Atrophy, the leading cause of irreversible blindness in adults over 60.
